An incremental cost-effectiveness analysis of the first, second and third sputum examination in the diagnosis of pulmonary tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 3, 2000, Pages 246-251

  Walker, Damian ^a   McNerney, R ^a   Kimankinda Mwembo, M ^b   Foster, S ^d   Tihon, V ^a,c   Godfrey Faussett, P ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b St Francis Hospital Katete   (Zambia)

^c UNIVERSITY TEACHING HOSPITAL   (Zambia)

^d London Sch of Hyg and Trop Med ^*

Author keywords

Cost effectiveness analysis; Diagnosis; Microscopy; Tuberculosis; Zambia

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RURAL HEALTH CARE; SPUTUM SMEAR; ZAMBIA;

COST OF ILLNESS; COST-BENEFIT ANALYSIS; HUMANS; SPUTUM; TUBERCULOSIS, PULMONARY; ZAMBIA;

EID: 0034061763     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. ZAMBART. TB control in an urban area with high TB and HIV prevalence: a study to determine to what extent diagnostic procedures are correctly applied in the urban health centres in Lusaka. Lusaka: ZAMBART, 1999.
2. World Health Organization. Global Tuberculosis Programme. Global Tuberculosis Control. WHO Report 1998. Geneva: WHO, 1998.
3. Buve A, Foster S D, Mbwili C, Mungo E, Tollenare N, Zeko M. Mortality among female nurses in the face of the AIDS epidemic: a pilot study in Zambia. AIDS 1994; 8: 396.
4. Enarson D A, Rieder H L, Arnadottir T. Tuberculosis guide for low income countries. 3rd ed. Paris: International Union Against Tuberculosis and Lung Disease, 1994.
5. The National AIDS/STD/TB and Leprosy Programme. TB Manual. Lusaka: Ministry of Health, Republic of Zambia, 1995.
6. Rieder H L, Chonde T M, Myking H, et al. The Public Health Service National Tuberculosis Reference Laboratory and the National Laboratory Network: minimum requirements, role and operation in a low-income country. Paris: International Union Against Tuberculosis and Lung Disease, 1998.
7. Kuusi M. Tuberculosis. In: Lankinen K, Bergstrom S, Makela P, Pelotomaa M, eds. Health and disease in developing countries. London: The Macmillan Press Limited, 1994: pp 177-184.
8. Needham D M, Godfrey-Faussett P. Economic barriers for tuberculosis patients in Zambia. Lancet 1996; 348: 134-135.
9. Needham D M, Godfrey-Faussett P, Foster S D. Barriers to tuberculosis control in urban Zambia: the economic impact and burden on patients prior to diagnosis. Int J Tuberc Lung Dis 1998; 2: 811-817.
10. The World Bank. World Development Report: Investing in Health. New York: Oxford University Press, 1993.
11. Creese A, Parker D. Cost analysis in primary health care: A training manual for programme managers. Geneva: World Health Organization, 1994.
12. Central Board of Health Zambia. Quantification of Medical Supplies. Lusaka: Central Board of Health, 1998.
13. Drummond M, O'Brien B, Stoddart G, Torrance G. Methods for the economic evaluation of health care programmes. 2nd ed. Oxford: Oxford University Press, 1997.
14. Ipuge Y A, Rieder H L, Enarson D A. The yield of acid-fast bacilli from serial smears in routine microscopy laboratories in rural Tanzania. Trans Roy Soc Trop Med Hyg 1996; 90: 258-261.
15. Foster S. The economics of tuberculosis diagnosis and treatment. In: Porter J D H, Grange J M, eds. Tuberculosis: an interdisciplinary perspective. London: Imperial College Press, 1999.
16. Squire S B, Nyasulu I K, Amali R, Kanyerere H, Salaniponi F M L. Is smear-microscopy functioning as case-finding strategy for tuberculosis in Africa? Tubercle Lung Dis 1996; 77 (Suppl 2): 77.
17. Royston G. Commentary: trials versus models in appraising screening programmes. BMJ 1999; 318: 360-361.